Biological screening of natural products and drug innovation in China
- 22 February 2007
- journal article
- review article
- Published by The Royal Society in Philosophical Transactions Of The Royal Society B-Biological Sciences
- Vol. 362 (1482) , 1093-1105
- https://doi.org/10.1098/rstb.2007.2036
Abstract
Natural products have been applied to human healthcare for thousands of years. Drug discovery in ancient times was largely by chance and based on clinical practices. As understanding of therapeutic benefits deepens and demands for natural products increase, previously serendipitous discoveries evolve into active searches for new medicines. Many drugs presently prescribed by physicians are either directly isolated from plants or are artificially modified versions of natural products. Scientists are looking for lead compounds with specific structures and pharmacological effects often from natural sources. Experiences and successes of Chinese scientists in this specialized area have resulted in a number of widely used drugs. The tremendous progress made in life sciences has not only revealed many pathological processes of diseases, but also led to the establishment of various molecular and cellular bioassays in conjunction with high-throughput technologies. This is advantageous and permits certain natural compounds that are difficult to isolate and purify, and compounds that are difficult to synthesize, to be assayed. The transition from traditional to empirical and to molecular screening will certainly increase the probability of discovering new leads and drug candidates from natural products.Keywords
This publication has 72 references indexed in Scilit:
- Retinoic Acid and Arsenic for Treating Acute Promyelocytic LeukemiaPLoS Medicine, 2005
- Multicomponent therapeutics for networked systemsNature Reviews Drug Discovery, 2005
- Effects of artemisinin-tagged holotransferrin on cancer cellsLife Sciences, 2004
- Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicineZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Identification of Phase I and Phase II metabolites of Guanfu base a Hydrochloride in human urineEuropean Journal of Drug Metabolism and Pharmacokinetics, 2003
- Inhibition of Activator Protein 1 Activity by Berberine in Human Hepatoma CellsPlanta Medica, 1999
- Screensavers: trends in high-throughput analysisTrends in Biotechnology, 1999
- Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhizae Radix in the ratGeneral Pharmacology: The Vascular System, 1994
- Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhizaLife Sciences, 1993
- BN 52021 and related compounds: A new series of highly specific paf-acether receptor antagonistsInternational Journal of Immunopharmacology, 1985